Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on July 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

GLOBULIN, RHO (D) IMMUN

Closed
SPE2DP-26-T-4378Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

GLOBULIN RHO (D) IMMUNE, USP, 300 MICROGRAMS, is a prescription-only injectable medicinal product intended for intramuscular administration only, supplied in a single-use 1 mL syringe with safety features. Each unit is packaged individually, with a total quantity of two units required under this procurement. The product must be stored at a temperature between 2 to 8 degrees Celsius and must not be frozen. The National Stock Number is 6505-01-417-1250, and delivery is scheduled within 20 days after award. This item is regulated by the FDA and classified as a hazardous material, requiring a current Material Safety Data Sheet (MSDS) to be submitted electronically to DLA.MSDS@DLA.MIL and physically included with each shipment. Packaging must conform to applicable hazardous materials regulations including 49 CFR and ICAO standards. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, and the revision in effect on the solicitation issue date controls compliance. The procurement is issued under solicitation SPE2DP-26-T-4378, posted on July 29, 2026, with responses due by August 4, 2026. The contracting activity is the Department of Defense, Medical Supply Chain PHARM FSA, with James Foggie as the primary point of contact. Covered defense information may apply, and government identification must be removed from non-accepted supplies.

General Info

300 mcg GLOBULIN RHO (D) IMMUNE, USP, two units, 2–8°C storage, hazardous, FDA-regulated, delivery in 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100206 BOX 1, FPO, AP, 96666, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4378 Medical Supply Chain Pharm FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA

Full Description

Show more
GLOBULIN,RHO (D) IMMUNE
GLOBULIN<(>,<)> RHO (D) IMMUNE, USP, 300 MCG, 1'S. 300 MICROGRAMS; ADULT
DOSE; DISPOSABLE; 1ML SYRINGE WITH SAFETY; INJECT ONLY INTRAMUSCULARLY;
UNIT OF ISSUE "EACH. STORE AT 2-8 DEG.C; DO NOT FREEZE; DISPENSE
BYPRESCRIPTION ONLY.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RQ034: HAZARDOUS COMMUNICATION STANDARD NOTICE
.
HAZARDOUS MATERIALS REQUIREMENTS.
.
MATERIAL SAFETY DATA SHEET (MSDS).
.
. A CURRENT MSDS SHALL BE PROVIDED FOR THIS
ITEM. DLA'S DOD HMIRS FOCAL POINT (VBA) HAS
ESTABLISHED AN ELECTRONIC MAILBOX TO WHICH
ONE CAN TRANSMIT THE MSDS, TOGETHER WITH THE
COVER SHEET (P-75) WHOSE CONTENTS ARE TO
REFLECT LOGISTICS INFORMATION PROPER TO THE
MSDS ASSOCIATED WITH THE AWARDED CONTRACT AND
NSN. THE ELECTRONIC MAILBOX ADDRESS IS
DLA.MSDS@DLA.MIL.
.
. IN ADDITION, A COPY OF THE MSDS SHALL
ACCOMPANY EACH SHIPMENT OF THIS ITEM.
.
PACKAGING.
.
. PACKAGING FOR HAZARDOUS MATERIALS SHALL
COMPLY WITH APPLICABLE REGULATIONS, I.E.,
49 CFR, INTERNATIONAL CIVIL AVIATION
ORGANIZATION (ICAO) TECHNICAL NSN/Part Number: 6505-01-417-1250 Quantity: 2 EA Purchase Request: 7017651332QTY: 2 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS